<p>Today’s episode is an update on AML (acute myeloid leukemia). In Part 2 we discuss the treatment options for first-line, as well as relapsed/refractory disease. We are so honored to have Dr. Catherine Lai here with us who is Associate Professor and Physician Leader of the Leukemia Clinical Research Unit at UPenn.</p>

Today’s episode is an update on AML (acute myeloid leukemia). In Part 2 we discuss the treatment options for first-line, as well as relapsed/refractory disease. We are so honored to have Dr. Catherine Lai here with us who is Associate Professor and Physician Leader of the Leukemia Clinical Research Unit at UPenn.

Acute Myeloid Leukemia (AML) 2024 x Dr. Catherine Lai Part 2

This is Sam and Karine, and we are Two Onc Docs! We both graduated from our Heme/Onc fellowships in 2021 and became board certified in both Hematology and Oncology. Our mission with Two Onc Docs is to create short board review episodes that you can listen to on your drive to work, while you make your morning coffee, or between pages on call. This is intended to be a supplement to other established board studying resources for busy trainees. *This podcast is intended to be an educational resource for health care providers.*

Share Acute Myeloid Leukemia (AML) 2024 x Dr. Catherine Lai Part 2

Sign up to save your podcasts

Acute Myeloid Leukemia (AML) 2024 x Dr. Catherine Lai Part 2

Acute Myeloid Leukemia (AML) 2024 x Dr. Catherine Lai Part 2

More shows like Two Onc Docs

NEJM This Week

JAMA Clinical Reviews

ASCO Daily News

Mayo Clinic Talks

The Curbsiders Internal Medicine Podcast

Core IM | Internal Medicine Podcast

The ONS Podcast

ASCO Guidelines

The Clinical Problem Solvers

Harrison's PodClass: Internal Medicine Cases and Board Prep

Run the List

The Medbullets Step 2 & 3 Podcast

Oncology Today with Dr Neil Love

The Curious Clinicians

Oncology Brothers: Practice-Changing Cancer Discussions